Placebo formulation

DIETARY_SUPPLEMENT4 trials

Sponsors

DBV Technologies, University of Colorado, Denver, Centro de Investigación en Alimentación y Desarrollo A.C., Fudan University

Conditions

Angelman SyndromeLactationMothersPeanut AllergyTriple Negative Breast Cancer

Phase 1

Safety of Epicutaneous Immunotherapy for the Treatment of Peanut Allergy

CompletedNCT01170286

DBV TechnologiesPeanut Allergy

Start: 2010-07-31End: 2012-02-29Updated: 2012-03-23

Phase 3

Evaluating the Clinical Value of Traditional Chinese Medicine in the Adjuvant Therapy of Triple-negative Breast Cancer

Fudan UniversityTriple Negative Breast Cancer

Start: 2020-05-25End: 2024-05-31Target: 200Updated: 2020-06-01

Unknown Phase

Nutritional Formulation for Angelman Syndrome

CompletedNCT03644693

University of Colorado, DenverAngelman Syndrome

Start: 2018-11-01End: 2020-01-15Updated: 2020-08-20

Effect of Intracellular Content From Lactobacillus Casei CRL-431 on Antioxidant Capacity of Breast Milk

CompletedNCT04335708

Centro de Investigación en Alimentación y Desarrollo A.C.Lactation, Mothers

Start: 2018-12-01End: 2019-04-30Updated: 2023-10-05

Related Papers

Nutritional Formulation for Patients with Angelman Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study of Exogenous Ketones.

2021-12-0112 citations

Evaluation of the safety and tolerability of a nutritional Formulation in patients with ANgelman Syndrome (FANS): study protocol for a randomized controlled trial

Trials2020-01-0912 citations